恩文特电气

最新新闻

• 公司公告
  Blue Sail Medical: Lanfan Medical Co., Ltd. plans to use the goodwill impairment test for financial reporting purposes involving an asset assessment report on the amount of asset group where the goodwill is located after merging NVT AG's aortic valve intervention business
  SZSI · 2024/4/27
• Roth MKM Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $210
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $218
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• 评级变动
  Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $220
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• UBS Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $225
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Roth MKM Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $185
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• BMO Capital Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $212
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Goldman Sachs Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $200
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• 评级变动
  Clear Street Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $260
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  A Quick Look at Today's Ratings for NVent Electric(NVT.US), With a Forecast Between $195 to $225
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 评级变动
  Bernstein Initiates NVent Electric(NVT.US) With Buy Rating, Announces Target Price $218
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $229
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• BMO Capital Initiates NVent Electric(NVT.US) With Buy Rating, Announces Target Price $212
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Wolfe Research Initiates NVent Electric(NVT.US) With Buy Rating, Announces Target Price $191
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 评级变动
  Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $220
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  RBC Capital Maintains NVent Electric(NVT.US) With Buy Rating, Raises Target Price to $193
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Baird Initiates NVent Electric(NVT.US) With Buy Rating, Announces Target Price $188
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $229
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 公司公告
  Blue Sail Medical: Blue Sail Medical Co., Ltd. plans to use the goodwill impairment test for financial reporting purposes involving an asset assessment report on the amount of recoverable asset group portfolio of goodwill after merging NVT AG\'s aortic valve intervention business
  SZSI · 2025/4/29
• 评级变动
  Melius Research Initiates NVent Electric(NVT.US) With Buy Rating, Announces Target Price $214
  \u5e02\u573a\u8d44\u8baf · 2026/6/16
• 评级变动
  William Blair Maintains NVent Electric(NVT.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• Bernstein Maintains NVent Electric(NVT.US) With Buy Rating, Maintains Target Price $229
  \u5e02\u573a\u8d44\u8baf · 2026/9/21

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。